LncRNA HOTAIR Regulates CCND1 and CCND2 Expression by Sponging miR-206 in Ovarian Cancer

被引:114
|
作者
Chang, Lei [1 ]
Guo, Ruixia [1 ]
Yuan, Zhongfu [1 ]
Shi, Huirong [1 ]
Zhang, Dongya [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Gynecol, 1 East Jianshe Rd, Zhengzhou 450000, Henan, Peoples R China
基金
中国博士后科学基金;
关键词
LncRNA HOTAIR; miR-206; CCND1; CCND2; Ovarian cancer; COMPETING ENDOGENOUS RNA; LONG NONCODING RNAS; CYCLIN D1; CELL-CYCLE; PROGRESSION; OVEREXPRESSION; PROLIFERATION; MICRORNAS; OSTEOSARCOMA; PROGNOSIS;
D O I
10.1159/000493408
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: The long noncoding RNA homeobox (HOX) transcript antisense intergenic RNA (HOTAIR) has been demonstrated to be a vital modulator in the proliferation and metastasis of ovarian cancer cells, but its potential molecular mechanism remains to be elucidated. In the current study, we aimed to uncover the biological role of IncRNA HOTAIR and its underlying regulatory mechanism in the progression and metastasis of ovarian cancer. Methods: HOTAIR expression was detected by quantitative RT-PCR (qRT-PCR) and northern blotting. The SKOV3 ovarian cancer cell line was chosen for the subsequent assays. In addition, the molecular mRNA and protein expression levels were examined by qRT-PCR and western blotting. The competitive endogenous RNA (ceRNA) mechanism was validated by bioinformatics analysis and a dual luciferase reporter gene assay. Results: HOTAIR expression was significantly higher in ovarian carcinoma tissues and cell lines than in the control counterparts. Both CCND1 and CCND2 were downstream targets of miR-206. The inhibition of HOTAIR elevated the expression of miR-206 and inhibited the expression of CCND1 and CCND2. Moreover, CCND1 and CCND2 were highly expressed in ovarian cancer tissues, and their expression was positively correlated with HOTAIR expression. Finally, the functional assays indicated that the anticancer effects of miR-206 could be rescued by the simultaneous overexpression of either CCND1 or CCND2 in ovarian cancer. Conclusion: HOTAIR enhanced CCND1 and CCND2 expression by negatively modulating miR-206 expression and stimulating the proliferation, cell cycle progression, migration and invasion of ovarian cancer cells. (C) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:1289 / 1303
页数:15
相关论文
共 50 条
  • [41] Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia
    A-K Eisfeld
    J Kohlschmidt
    S Schwind
    D Nicolet
    J S Blachly
    S Orwick
    C Shah
    M Bainazar
    K W Kroll
    C J Walker
    A J Carroll
    B L Powell
    R M Stone
    J E Kolitz
    M R Baer
    A de la Chapelle
    K Mrózek
    J C Byrd
    C D Bloomfield
    Leukemia, 2017, 31 : 1278 - 1285
  • [42] Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia
    Eisfeld, A-K
    Kohlschmidt, J.
    Schwind, S.
    Nicolet, D.
    Blachly, J. S.
    Orwick, S.
    Shah, C.
    Bainazar, M.
    Kroll, K. W.
    Walker, C. J.
    Carroll, A. J.
    Powell, B. L.
    Stone, R. M.
    Kolitz, J. E.
    Baer, M. R.
    de la Chapelle, A.
    Mrozek, K.
    Byrd, J. C.
    Bloomfield, C. D.
    LEUKEMIA, 2017, 31 (06) : 1278 - 1285
  • [43] FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner
    Deng, Kaiping
    Zhang, Zhen
    Ren, Caifang
    Liang, Yaxu
    Gao, Xiaoxiao
    Fan, Yixuan
    Wang, Feng
    EXPERIMENTAL CELL RESEARCH, 2021, 401 (02)
  • [44] Significance of miR-3663-3p via CCND1 pathway in gastric cancer progression
    Yamamoto, Taiga
    Konishi, Hirotaka
    Takao, Koji
    Shibata, Rie
    Kataoka, Satoshi
    Shibamoto, Jun
    Furuke, Hirotaka
    Takaki, Wataru
    Arita, Tomohiro
    Ohashi, Takuma
    Shimizu, Hiroki
    Shiozaki, Atsushi
    Kubota, Takeshi
    Fujiwara, Hitoshi
    Otsuji, Eigo
    CANCER SCIENCE, 2023, 114 : 1874 - 1874
  • [45] JARID2 inhibits leukemia cell proliferation by regulating CCND1 expression
    Su, Chang-Liang
    Deng, Tao-Ran
    Shang, Zhen
    Xiao, Yi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (01) : 76 - 85
  • [46] JARID2 inhibits leukemia cell proliferation by regulating CCND1 expression
    Chang-Liang Su
    Tao-Ran Deng
    Zhen Shang
    Yi Xiao
    International Journal of Hematology, 2015, 102 : 76 - 85
  • [47] HOTAIR maintains the stemness of ovarian cancer stem cells via the miR-206/TBX3 axis
    Zhang, Yifan
    Guo, Jianfeng
    Cai, E.
    Cai, Jing
    Wen, Yiping
    Lu, Shi
    Li, Xiaoyan
    Han, Qing
    Jiang, Jiahong
    Li, Tao
    Wang, Zehua
    EXPERIMENTAL CELL RESEARCH, 2020, 395 (02)
  • [48] MiR-93-5p regulates tumorigenesis and tumor immunity by targeting PD-L1/CCND1 in breast cancer
    Yang, Meng
    Xiao, Ran
    Wang, Xinru
    Xiong, Youyi
    Duan, Zhenfeng
    Li, Duolu
    Kan, Quancheng
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (04)
  • [49] Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients
    Betticher, DC
    Heighway, J
    Thatcher, N
    Hasleton, PS
    BRITISH JOURNAL OF CANCER, 1997, 75 (12) : 1761 - 1768
  • [50] MiR-3663-3p Inhibits the Progression of Gastric Cancer Through the CCND1 Pathway
    TAKAO, K. O. J., I
    KONISHI, H. I. R. O. T. A. K. A.
    MATSUBARA, D. A. I. K. I.
    SHODA, K. A. T. S. U. T. O. S. H., I
    ARITA, T. O. M. O. H. I. R. O.
    SHIMIZU, H. I. R. O. K. I.
    KOMATSU, S. H. U. H. E., I
    SHIOZAKI, A. T. S. U. S. H. I.
    YAMAMOTO, Y. U. S. U. K. E.
    KUBOTA, T. A. K. E. S. H., I
    FUJIWARA, H. I. T. O. S. H. I.
    OKAMOTO, K. A. Z. U. M. A.
    OTSUJI, E. I. G. O.
    ANTICANCER RESEARCH, 2021, 41 (05) : 2441 - 2449